Citation

Athe Tsibris, Kay E. Leopold, Roger Paredes, Eoin Coakley, Zhaohui Su, Wayne Greaves, Roy (Trip) Gulick, Daniel R. Kuritzkes. Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressures. Journal of Virology. 2012. 86: 6416-26. PMID: 22491471

Citation

Association of HIV viral load and CD4 cell count with human papillomavirus detection and clearance in HIV-infected women initiating highly active antiretroviral therapy. HIV Medicine. 2012. 13: 372-8. PMID: 22257000

Citation

Robert J. McLinden. Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170). AIDS. 2012. 26: 1-9. PMID: 21971356

Citation

A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4 T-cell recovery despite sustained virologic suppression: ACTG A5256. Journal of Infectious Diseases. 2012. 206: 534-42. PMID: 22740718

Citation

The Setpoint Study (ACTG A5217): Effect of Immediate Versus Deferred Antiretroviral Therapy on Virologic Set Point in Recently HIV-1-Infected Individuals.. Journal of Infectious Diseases. 2012. 205: 87-96. PMID: 22180621

Citation

Sharon L. Nichols, Grace Montepiedra, Patricia Sirois, John J. Farley, Kathleen Malee, Betsy Kammerer, Patricia A. Garvie, Sylvie Naar-King. Cognitive, Academic and Behavioral Correlates of Medication Adherence in Children and Adolescents with Perinatally Acquired HIV-1 Infection. Journal of Developmental Pediatrics. 2012. 33: 298-308. PMID: 22366661

Citation

Host gene expression changes correlating with anti-HIV-1 effects in human subjects after treatment with peginterferon Alfa-2a. AIDS. 2012. 205: 1443-7. PMID: 22454462

Citation

Drug Resistance and Coreceptor Usage in HIV-1 Subtype C Infected Children Initiating or Failing Highly Active Antiretroviral Therapy in South Africa. AIDS Research and Human Retroviruses. 2012. 28: 324-32. PMID: 21819257

Citation

The Pharmacogenetics of NAT2 Enzyme Maturation in Perinatally HIV Exposed Infants Receiving Isoniazid. Clinical Pharmacology & Therapeutics. 2012. 52: 511-9. PMID: 21558457

Citation

S Madhi, S Nachman, H S Schaaf, A Violari, T C Victor, G McSherry, C Mitchell, M F Cotton, IMPAACT P1041 Team, A C Hesseling, S Kim. High prevalence of drug resistance amongst HIV-exposed and -infected children in a tuberculosis prevention trial. International Journal of Tuberculosis and Lung Disease. 2012. 16: 192-195. PMID: 22236919